Company news

Nexalis Therapeutics Limited news in 2025

Nexalis Therapeutics Limited's news releases, calls and decks from 2025, newest first.

View company

IRX Overview Presentation - SRX-25 and Nexalis

December 9, 2025

$12.6m Facility to Drive SRX-25 Development

December 3, 2025

Prospectus - Non-Renounceable Rights Issue Offer

November 26, 2025

Drug Development Pipeline Bolstered and Capital Raise

November 26, 2025

Trading Halt

November 23, 2025

Sep25 Quarterly Activities Report

October 31, 2025

Sep25 Appendix 4C Cash Flow Report

October 31, 2025

Half Yearly Report and Accounts

August 25, 2025

Jun25 Quarterly Activities Report

July 22, 2025

Jun25 Appendix 4C Cash Flow Report

July 22, 2025

Mar25 Quarterly Activities Report

April 28, 2025

Mar25 Appendix 4C Cash Flow Report

April 28, 2025

IRX Completes First Drawdown Under Clendon Facility

April 24, 2025

IRX-616a Study Order Executed to Commence Phase 1

April 17, 2025

Study Order Executed for Phase 2 BTcP Trial

March 13, 2025

Updated Dec24 Quarterly Activities Report

January 24, 2025

Dec24 Quarterly Activities Report

January 23, 2025

Dec24 Appendix 4C Cash Flow Report

January 23, 2025

Decks in 2025